Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Peter Devilee

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Genes & Molecular Sequences

Physiology

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Middeldorp Anneke; Jagmohan-Changur Shantie; van Eijk Ronald; Tops Carli; Devilee Peter; Vasen Hans F A; Hes Frederik J; Houlston Richard; Tomlinson Ian; Houwing-Duistermaat Jeanine J; Wijnen Juul T; Morreau Hans; van Wezel Tom
Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.
Rosa-Rosa Juan Manuel; Pita Guillermo; González-Neira Anna; Milne Roger L; Fernandez Victoria; Ruivenkamp Claudia; van Asperen Christi J; Devilee Peter; Benitez Javier
A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer.
Bayley Jean-Pierre; Weiss Marjan M; Grimbergen Anneliese; van Brussel Bernadette T J; Hes Frederik J; Jansen Jeroen C; Verhoef Senno; Devilee Peter; Corssmit Eleonora P; Vriends Annette H J T
Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Peter Devilee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Middeldorp Anneke; Jagmohan-Changur Shantie; van Eijk Ronald; Tops Carli; Devilee Peter; Vasen Hans F A; Hes Frederik J; Houlston Richard; Tomlinson Ian; Houwing-Duistermaat Jeanine J; Wijnen Juul T; Morreau Hans; van Wezel Tom
Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(11):3062-7.
2009: Rosa-Rosa Juan Manuel; Pita Guillermo; González-Neira Anna; Milne Roger L; Fernandez Victoria; Ruivenkamp Claudia; van Asperen Christi J; Devilee Peter; Benitez Javier
A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer.
Breast cancer research and treatment 2009;118(1):151-9.
2009: Bayley Jean-Pierre; Weiss Marjan M; Grimbergen Anneliese; van Brussel Bernadette T J; Hes Frederik J; Jansen Jeroen C; Verhoef Senno; Devilee Peter; Corssmit Eleonora P; Vriends Annette H J T
Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Endocrine-related cancer 2009;16(3):929-37.
2009: Hao Huai-Xiang; Khalimonchuk Oleh; Schraders Margit; Dephoure Noah; Bayley Jean-Pierre; Kunst Henricus; Devilee Peter; Cremers Cor W R J; Schiffman Joshua D; Bentz Brandon G; Gygi Steven P; Winge Dennis R; Kremer Hannie; Rutter Jared
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.
Science (New York, N.Y.) 2009;325(5944):1139-42.
2009: Koelink Pim J; Robanus-Maandag Els C; Devilee Peter; Hommes Daniel W; Lamers Cornelis B H W; Verspaget Hein W
5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.
Carcinogenesis 2009;30(7):1217-24.
2009: Ulybina Yulia M; Kuligina Ekatherina Sh; Mitiushkina Nathalia V; Rozanov Maxim E; Ivantsov Alexandr O; Ponomariova Daria N; Togo Alexandr V; Levchenko Evgeny V; Shutkin Vladimir A; Brenister Sergiu I; Devilee Peter; Zhivotovsky Boris; Hirvonen Ari; Imyanitov Evgeny N
Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer.
Cancer letters 2009;278(2):183-91.
2009: Wijnen Juul T; Brohet Richard M; van Eijk Ronald; Jagmohan-Changur Shanty; Middeldorp Anneke; Tops Carli M; van Puijenbroek Mario; Ausems Margreet G E M; Gómez García Encarna; Hes Frederik J; Hoogerbrugge Nicoline; Menko Fred H; van Os Theo A M; Sijmons Rolf H; Verhoef Senno; Wagner Anja; Nagengast Fokko M; Kleibeuker Jan H; Devilee Peter; Morreau Hans; Goldgar David; Tomlinson Ian P; Houlston Richard S; van Wezel Tom; Vasen Hans F A
Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
Gastroenterology 2009;136(1):131-7.
2009: Vreeswijk Maaike P G; Kraan Jaennelle N; van der Klift Heleen M; Vink Geraldine R; Cornelisse Cees J; Wijnen Juul T; Bakker Egbert; van Asperen Christi J; Devilee Peter
Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs.
Human mutation 2009;30(1):107-14.
2009: Cervera Ana M; Bayley Jean-Pierre; Devilee Peter; McCreath Kenneth J
Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells.
Molecular cancer 2009;8():89.
2009: Mohammadi Leila; Vreeswijk Maaike P; Oldenburg Rogier; van den Ouweland Ans; Oosterwijk Jan C; van der Hout Annemarie H; Hoogerbrugge Nicoline; Ligtenberg Marjolijn; Ausems Margreet G; van der Luijt Rob B; Dommering Charlotte J; Gille Johan J; Verhoef Senno; Hogervorst Frans B; van Os Theo A; Gómez García Encarna; Blok Marinus J; Wijnen Juul T; Helmer Quinta; Devilee Peter; van Asperen Christi J; van Houwelingen Hans C
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.
BMC cancer 2009;9():211.
2009: Jonsdottir Asta Björk; Vreeswijk Maaike P G; Wolterbeek Ron; Devilee Peter; Tanke Hans J; Eyfjörd Jorunn E; Szuhai Karoly
BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2009;31(3):191-201.
2009: Hensen Erik F; Goeman Jelle J; Oosting Jan; Van der Mey Andel Gl; Hogendoorn Pancras Cw; Cremers Cor Wrj; Devilee Peter; Cornelisse Cees J
Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis.
BMC medical genomics 2009;2():25.
2009: Bayley Jean-Pierre; Grimbergen Anneliese E M; van Bunderen Patrick A; van der Wielen Michiel; Kunst Henricus P; Lenders Jacques W; Jansen Jeroen C; Dullaart Robin P F; Devilee Peter; Corssmit Eleonora P; Vriends Annette H; Losekoot Monique; Weiss Marjan M
The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients.
BMC medical genetics 2009;10():34.
2009: Gómez García Encarna B; Oosterwijk Jan C; Timmermans Maarten; van Asperen Christi J; Hogervorst Frans B L; Hoogerbrugge Nicoline; Oldenburg Rogier; Verhoef Senno; Dommering Charlotte J; Ausems Margreet G E M; van Os Theo A M; van der Hout Annemarie H; Ligtenberg Marjolijn; van den Ouweland Ans; van der Luijt Rob B; Wijnen Juul T; Gille Jan J P; Lindsey Patrick J; Devilee Peter; Blok Marinus J; Vreeswijk Maaike P G
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.
Breast cancer research : BCR 2009;11(1):R8.
2008: Oldenburg Rogier A; Kroeze-Jansema Karin H G; Houwing-Duistermaat Jeanine J; Bayley Jean-Pierre; Dambrot Cheryl; van Asperen Christi J; van den Ouweland Ans M W; Bakker Bert; van Beers Erik H; Nederlof Petra M; Vasen Hans; Hoogerbrugge Nicoline; Cornelisse Cees J; Meijers-Heijboer Hanne; Devilee Peter
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus.
Genes, chromosomes & cancer 2008;47(11):947-56.
2008: de Bock Geertruida H; Jacobi Catharina E; Seynaeve Caroline; Krol-Warmerdam Elly M M; Blom Jannet; van Asperen Christi J; Cornelisse Cees J; Klijn Jan G M; Devilee Peter; Tollenaar Rob A E M; Brekelmans Cecile T M; van Houwelingen Johannes C
A family history of breast cancer will not predict female early onset breast cancer in a population-based setting.
BMC cancer 2008;8():203.
2007: Lehtonen Heli J; Mäkinen Markus J; Kiuru Maija; Laiho Päivi; Herva Riitta; van Minderhout Ivonne; Hogendoorn Pancras C W; Cornelisse Cees; Devilee Peter; Launonen Virpi; Aaltonen Lauri A
Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
International journal of cancer. Journal international du cancer 2007;121(6):1386-9.
2007: Oldenburg R A; Meijers-Heijboer H; Cornelisse C J; Devilee P
Genetic susceptibility for breast cancer: how many more genes to be found?
Critical reviews in oncology/hematology 2007;63(2):125-49.
2007: Imyanitov Evgeny N; Cornelisse Cees J; Devilee Peter
Searching for susceptibility alleles: emphasis on bilateral breast cancer.
International journal of cancer. Journal international du cancer 2007;121(4):921-3.
2007: Jacobi Catharina E; van Ierland Yvette; van Asperen Christi J; Hallensleben Eric; Devilee Peter; Jan Fleuren Gert; Kenter Gemma G
Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort.
Genetics in medicine : official journal of the American College of Medical Genetics 2007;9(3):173-9.
2007: Huijts Petra E A; Vreeswijk Maaike P G; Kroeze-Jansema Karin H G; Jacobi Catharina E; Seynaeve Caroline; Krol-Warmerdam Elly M M; Wijers-Koster Pauline M; Blom Jannet C; Pooley Karen A; Klijn Jan G M; Tollenaar Rob A E M; Devilee Peter; van Asperen Christi J
Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
Breast cancer research : BCR 2007;9(6):R78.
2007: Gonzalez-Neira Anna; Rosa-Rosa Juan Manuel; Osorio Ana; Gonzalez Emilio; Southey Melissa; Sinilnikova Olga; Lynch Henry; Oldenburg Rogier A; van Asperen Christi J; Hoogerbrugge Nicoline; Pita Guillermo; Devilee Peter; Goldgar David; Benitez Javier
Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies.
BMC genomics 2007;8():299.
2007: Sokolenko Anna P; Rozanov Maxim E; Mitiushkina Natalia V; Sherina Natalia Yu; Iyevleva Aglaya G; Chekmariova Elena V; Buslov Konstantin G; Shilov Evgeny S; Togo Alexandr V; Bit-Sava Elena M; Voskresenskiy Dmitry A; Chagunava Oleg L; Devilee Peter; Cornelisse Cees; Semiglazov Vladimir F; Imyanitov Evgeny N
Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.
Familial cancer 2007;6(3):281-6.
2007: Middeldorp Anneke; Jagmohan-Changur Shantie; Helmer Quinta; van der Klift Heleen M; Tops Carli M J; Vasen Hans F A; Devilee Peter; Morreau Hans; Houwing-Duistermaat Jeanine J; Wijnen Juul T; van Wezel Tom
A procedure for the detection of linkage with high density SNP arrays in a large pedigree with colorectal cancer.
BMC cancer 2007;7():6.
2006: Chekmariova Elena V; Sokolenko Anna P; Buslov Konstantin G; Iyevleva Aglaya G; Ulibina Yulia M; Rozanov Maxim E; Mitiushkina Natalia V; Togo Alexandr V; Matsko Dmitry E; Voskresenskiy Dmitry A; Chagunava Oleg L; Devilee Peter; Cornelisse Cees; Semiglazov Vladimir F; Imyanitov Evgeny N
CHEK2 1100delC mutation is frequent among Russian breast cancer patients.
Breast cancer research and treatment 2006;100(1):99-102.
2006: Sokolenko Anna P; Mitiushkina Natalia V; Buslov Konstantin G; Bit-Sava Elena M; Iyevleva Aglaya G; Chekmariova Elena V; Kuligina Ekatherina Sh; Ulibina Yulia M; Rozanov Maxim E; Suspitsin Evgeny N; Matsko Dmitry E; Chagunava Oleg L; Trofimov Dmitry Yu; Devilee Peter; Cornelisse Cees; Togo Alexandr V; Semiglazov Vladimir F; Imyanitov Evgeny N
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2006;42(10):1380-4.
2006: Oldenburg Rogier A; Kroeze-Jansema Karin; Meijers-Heijboer Hanne; van Asperen Cristi J; Hoogerbrugge Nicoline; van Leeuwen Inge; Vasen Hans F A; Cleton-Jansen Anne-Marie; Kraan Jaennelle; Houwing-Duistermaat Jeanine J; Morreau Hans; Cornelisse Cees J; Devilee Peter
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1693-700.
2006: de Bock G H; Mourits M J E; Schutte M; Krol-Warmerdam E M M; Seynaeve C; Blom J; Brekelmans C T M; Meijers-Heijboer H; van Asperen C J; Cornelisse C J; Devilee P; Tollenaar R A E M; Klijn J G M
Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 2():552-5.
2006: Bayley Jean-Pierre; van Minderhout Ivonne; Weiss Marjan M; Jansen Jeroen C; Oomen Peter H N; Menko Fred H; Pasini Barbara; Ferrando Barbara; Wong Nora; Alpert Lesley C; Williams Rosie; Blair Edward; Devilee Peter; Taschner Peter E M
Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
BMC medical genetics 2006;7():1.
2005: Majdak Ewa Joanna; Debniak Jaroslaw; Milczek Tomasz; Cornelisse Cees J; Devilee Peter; Emerich Janusz; Jassem Jacek; De Bock Geertruida Hendrika
Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma.
Cancer 2005;104(5):1004-12.
2005: van Puijenbroek Marjo; van Asperen Christi J; van Mil Anneke; Devilee Peter; van Wezel Tom; Morreau Hans
Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.
The Journal of pathology 2005;206(2):198-204.
2005: Vink Geraldine R; van Asperen Christi J; Devilee Peter; Breuning Martijn H; Bakker Egbert
Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines.
European journal of human genetics : EJHG 2005;13(5):525-7.
2005: Buslov Konstantin G; Iyevleva Aglaya G; Chekmariova Elena V; Suspitsin Evgeny N; Togo Alexandr V; Kuligina Ekatherina Sh; Sokolenko Anna P; Matsko Dmitry E; Turkevich Elena A; Lazareva Yulia R; Chagunava Oleg L; Bit-Sava Elena M; Semiglazov Vladimir F; Devilee Peter; Cornelisse Cees; Hanson Kaido P; Imyanitov Evgeny N
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
International journal of cancer. Journal international du cancer 2005;114(4):585-9.
2005: van Beers Erik H; van Welsem Tibor; Wessels Lodewyk F A; Li Yunlei; Oldenburg Rogier A; Devilee Peter; Cornelisse Cees J; Verhoef Senno; Hogervorst Frans B L; van't Veer Laura J; Nederlof Petra M
Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
Cancer research 2005;65(3):822-7.
2005: Majdak Ewa J; De Bock Geertruida H; Brozek Izabela; Perkowska Magdalena; Ochman Karolina; Debniak Jaroslaw; Milczek Tomasz; Cornelisse Cees J; Jassem J; Emerich Janusz; Limon Janusz; Devilee Peter
Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary report.
European journal of cancer (Oxford, England : 1990) 2005;41(1):143-50.
2005: de la Hoya Miguel; Meijers-Heijboer Hanne; Fernández Juan Manuel; Díez Orland; Osorio Ana; Alonso Carmen; van Leeuwen Inge; Díaz-Rubio Eduardo; Cornelisse Cees; Benítez Javier; Devilee Peter; Caldés Trinidad
Mutant BRCA1 alleles transmission: different approaches and different biases.
International journal of cancer. Journal international du cancer 2005;113(1):166-7.
2005: Bayley Jean-Pierre; Devilee Peter; Taschner Peter E M
The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.
BMC medical genetics 2005;6():39.
2004: de Bock G H; Schutte M; Krol-Warmerdam E M M; Seynaeve C; Blom J; Brekelmans C T M; Meijers-Heijboer H; van Asperen C J; Cornelisse C J; Devilee P; Tollenaar R A E M; Klijn J G M
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.
Journal of medical genetics 2004;41(10):731-5.
2004: Hensen Erik F; Jordanova Ekaterina S; van Minderhout Ivonne J H M; Hogendoorn Pancras C W; Taschner Peter E M; van der Mey Andel G L; Devilee Peter; Cornelisse Cees J
Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families.
Oncogene 2004;23(23):4076-83.
2004: Oldenburg R A; de Vos tot Nederveen Cappel W H; van Puijenbroek M; van den Ouweland A; Bakker E; Griffioen G; Devilee P; Cornelisse C J; Meijers-Heijboer H; Vasen H F A; Morreau H
Extending the p16-Leiden tumour spectrum by respiratory tract tumours.
Journal of medical genetics 2004;41(3):e31.
2004: Szabo Csilla I; Schutte Mieke; Broeks Annegien; Houwing-Duistermaat Jeanine J; Thorstenson Yvonne R; Durocher Francine; Oldenburg Rogier A; Wasielewski Marijke; Odefrey Fabrice; Thompson Deborah; Floore Arno N; Kraan Jaennelle; Klijn Jan G M; van den Ouweland Ans M W; Wagner Teresa M U; Devilee Peter; Simard Jacques; van 't Veer Laura J; Goldgar David E; Meijers-Heijboer Hanne
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?
Cancer research 2004;64(3):840-3.
2003: Oldenburg Rogier A; Kroeze-Jansema Karin; Kraan Jaennelle; Morreau Hans; Klijn Jan G M; Hoogerbrugge Nicoline; Ligtenberg Marjolein J L; van Asperen Christi J; Vasen Hans F A; Meijers Carel; Meijers-Heijboer Hanne; de Bock Truuske H; Cornelisse Cees J; Devilee Peter
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.
Cancer research 2003;63(23):8153-7.
2003: van Asperen C J; Tollenaar R A E M; Krol-Warmerdam E M M; Blom J; Hoogendoorn W E; Seynaeve C M J C; Brekelmans C T M; Devilee P; Cornelisse C J; Klijn J G M; de Bock G H
Possible consequences of applying guidelines to healthy women with a family history of breast cancer.
European journal of human genetics : EJHG 2003;11(8):633-6.
2003: de Bock Geertruida H; Tollenaar Rob A E M; Papelard Hadewych; Vliet Vlieland Theodora P M; Devilee Peter; Cornelisse Cornelis J; Vandenbroucke Jan P
Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute 2003;95(13):1011-2; author reply 1012-3.
2003: Broeks Annegien; Urbanus Jos H M; de Knijff Peter; Devilee Peter; Nicke Marion; Klöpper Karin; Dörk Thilo; Floore Arno N; van't Veer Laura J
IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
Human mutation 2003;21(5):521-8.
2003: Hohenstein Peter; Molenaar Lia; Elsinga Joyce; Morreau Hans; van der Klift Heleen; Struijk Ada; Jagmohan-Changur Shantie; Smits Ron; van Kranen Henk; van Ommen Gert-Jan B; Cornelisse Cees; Devilee Peter; Fodde Riccardo
Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene.
Genes, chromosomes & cancer 2003;36(3):273-82.
2002: de la Hoya Miguel; Osorio Ana; Godino Javier; Sulleiro Sara; Tosar Alicia; Perez-Segura Pedro; Fernandez Cristina; Rodríguez Raquel; Díaz-Rubio Eduardo; Benítez Javier; Devilee Peter; Caldés Trinidad
Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.
International journal of cancer. Journal international du cancer 2002;97(4):466-71.
2001: Eng C; Brody L C; Wagner T M; Devilee P; Vijg J; Szabo C; Tavtigian S V; Nathanson K L; Ostrander E; Frank T S;
Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1.
Journal of medical genetics 2001;38(12):824-33.
2001: de Bock G H; Tollenaar R A; Papelard H; Cornelisse C J; Devilee P; van de Vijver M J
Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients.
British journal of cancer 2001;85(9):1347-50.
2001: Verhoog L C; van den Ouweland A M; Berns E; van Veghel-Plandsoen M M; van Staveren I L; Wagner A; Bartels C C; Tilanus-Linthorst M M; Devilee P; Seynaeve C; Halley D J; Niermeijer M F; Klijn J G; Meijers-Heijboer H
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.
European journal of cancer (Oxford, England : 1990) 2001;37(16):2082-90.
2001: Lodder L; Frets P G; Trijsburg R W; Tibben A; Meijers-Heijboer E J; Duivenvoorden H J; Wagner A; van Der Meer C A; Devilee P; Cornelisse C J; Niermeijer M F
Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
European journal of human genetics : EJHG 2001;9(7):492-500.
2001: Taschner P E; Jansen J C; Baysal B E; Bosch A; Rosenberg E H; Bröcker-Vriends A H; van Der Mey A G; van Ommen G J; Cornelisse C J; Devilee P
Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene.
Genes, chromosomes & cancer 2001;31(3):274-81.
2001: Hohenstein P; Kielman M F; Breukel C; Bennett L M; Wiseman R; Krimpenfort P; Cornelisse C; van Ommen G J; Devilee P; Fodde R
A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage.
Oncogene 2001;20(20):2544-50.
2001: van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E
Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.
International journal of oncology 2001;18(4):775-80.
2001: Baysal B E; Willett-Brozick J E; Taschner P E; Dauwerse J G; Devilee P; Devlin B
A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region.
European journal of human genetics : EJHG 2001;9(2):121-9.
2001: Stec I; van Vliet M; van Eijk R; Meijers H; Kroeze K H; Dauwerse J G; van Ommen G J; Cornelisse C J; den Dunnen J T; Devilee P
A partial BRCA1 sequence homology mapping to 4q28.
Cytogenetics and cell genetics 2001;94(1-2):26-9.
2000: Peelen T; de Leeuw W; van Lent K; Morreau H; van Eijk R; van Vliet M; Wijnen J; Ligtenberg M; Ginjaar H B; Zweemer R; Menko F; Fodde R; van Ommen G J; Vasen H F; Cornelisse C J; Devilee P
Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis.
International journal of cancer. Journal international du cancer 2000;88(5):778-82.
2000: Papelard H; de Bock G H; van Eijk R; Vliet Vlieland T P; Cornelisse C J; Devilee P; Tollenaar R A
Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients.
British journal of cancer 2000;83(6):719-24.
2000: Rahman N; Teare M D; Seal S; Renard H; Mangion J; Cour C; Thompson D; Shugart Y; Eccles D; Devilee P; Meijers H; Nathanson K L; Neuhausen S L; Weber B; Chang-Claude J; Easton D F; Goldgar D; Stratton M R
Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22.
Oncogene 2000;19(36):4170-3.
2000: Meijers-Heijboer E J; Verhoog L C; Brekelmans C T; Seynaeve C; Tilanus-Linthorst M M; Wagner A; Dukel L; Devilee P; van den Ouweland A M; van Geel A N; Klijn J G
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
Lancet 2000;355(9220):2015-20.
2000: Bonsing B A; Corver W E; Fleuren G J; Cleton-Jansen A M; Devilee P; Cornelisse C J
Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases.
Genes, chromosomes & cancer 2000;28(2):173-83.
2000: Van Der Looij M; Szabo C; Besznyak I; Liszka G; Csokay B; Pulay T; Toth J; Devilee P; King M C; Olah E
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
International journal of cancer. Journal international du cancer 2000;86(5):737-40.
2000: Berns E M; Foekens J A; Vossen R; Look M P; Devilee P; Henzen-Logmans S C; van Staveren I L; van Putten W L; Inganäs M; Meijer-van Gelder M E; Cornelisse C; Claassen C J; Portengen H; Bakker B; Klijn J G
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
Cancer research 2000;60(8):2155-62.
2000: van der Looij M; Cleton-Jansen A M; van Eijk R; Morreau H; van Vliet M; Kuipers-Dijkshoorn N; Oláh E; Cornelisse C J; Devilee P
A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1.
Genes, chromosomes & cancer 2000;27(3):295-302.
2000: Broeks A; Urbanus J H; Floore A N; Dahler E C; Klijn J G; Rutgers E J; Devilee P; Russell N S; van Leeuwen F E; van 't Veer L J
ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
American journal of human genetics 2000;66(2):494-500.
2000: Baysal B E; Ferrell R E; Willett-Brozick J E; Lawrence E C; Myssiorek D; Bosch A; van der Mey A; Taschner P E; Rubinstein W S; Myers E N; Richard C W; Cornelisse C J; Devilee P; Devlin B
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.
Science (New York, N.Y.) 2000;287(5454):848-51.
2000: Peelen T; van Vliet M; Bosch A; Bignell G; Vasen H F; Klijn J G; Meijers-Heijboer H; Stratton M; van Ommen G J; Cornelisse C J; Devilee P
Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families.
British journal of cancer 2000;82(1):151-6.
1999: van Slooten H J; van De Vijver M J; Borresen A L; Eyfjörd J E; Valgardsdóttir R; Scherneck S; Nesland J M; Devilee P; Cornelisse C J; van Dierendonck J H
Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.
The Journal of pathology 1999;189(4):504-13.
1999: Lodder L N; Frets P G; Trijsburg R W; Meijers-Heijboer E J; Klijn J G; Duivenvoorden H J; Tibben A; Wagner A; van der Meer C A; Devilee P; Cornelisse C J; Niermeijer M F
Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
Journal of medical genetics 1999;36(12):906-13.
1999: Verhoog L C; Brekelmans C T; Seynaeve C; Dahmen G; van Geel A N; Bartels C C; Tilanus-Linthorst M M; Wagner A; Devilee P; Halley D J; van den Ouweland A M; Meijers-Heijboer E J; Klijn J G
Survival in hereditary breast cancer associated with germline mutations of BRCA2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3396-402.
1999: Shugart Y Y; Cour C; Renard H; Lenoir G; Goldgar D; Teare D; Easton D; Rahman N; Gusterton R; Seal S; Barfoot R; Stratton M; Mangion J; Peelen T; van den Ouweland A; Meijers H; Devilee P; Eccles D; Lynch H; Weber B; Stoppa-Lyonnet D; Bignon Y J; Chang-Claude J
Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer.
Journal of medical genetics 1999;36(9):720-1.
1999: van Schothorst E M; Prins D E; Baysal B E; Beekman M; Licht J D; Waxman S; Zelent A; Cornelisse C J; van Ommen G J; Richard C W; Devilee P
Genomic structure of the human PLZF gene.
Gene 1999;236(1):21-4.
1999: Baysal B E; van Schothorst E M; Farr J E; Grashof P; Myssiorek D; Rubinstein W S; Taschner P; Cornelisse C J; Devlin B; Devilee P; Richard C W
Repositioning the hereditary paraganglioma critical region on chromosome band 11q23.
Human genetics 1999;104(3):219-25.
1999: Ligtenberg M J; Hogervorst F B; Willems H W; Arts P J; Brink G; Hageman S; Bosgoed E A; Van der Looij E; Rookus M A; Devilee P; Vos E M; Wigbout G; Struycken P M; Menko F H; Rutgers E J; Hoefsloot E H; Mariman E C; Brunner H G; Van 't Veer L J
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.
British journal of cancer 1999;79(9-10):1475-8.
1998: van Schothorst E M; Beekman M; Torremans P; Kuipers-Dijkshoorn N J; Wessels H W; Bardoel A F; van der Mey A G; van der Vijver M J; van Ommen G J; Devilee P; Cornelisse C J
Paragangliomas of the head and neck region show complete loss of heterozygosity at 11q22-q23 in chief cells and the flow-sorted DNA aneuploid fraction.
Human pathology 1998;29(10):1045-9.
1998: van Schothorst E M; Jansen J C; Grooters E; Prins D E; Wiersinga J J; van der Mey A G; van Ommen G J; Devilee P; Cornelisse C J
Founder effect at PGL1 in hereditary head and neck paraganglioma families from the Netherlands.
American journal of human genetics 1998;63(2):468-73.
1998: Wagner T M; Möslinger R A; Muhr D; Langbauer G; Hirtenlehner K; Concin H; Doeller W; Haid A; Lang A H; Mayer P; Ropp E; Kubista E; Amirimani B; Helbich T; Becherer A; Scheiner O; Breiteneder H; Borg A; Devilee P; Oefner P; Zielinski C
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics.
International journal of cancer. Journal international du cancer 1998;77(3):354-60.
1998: Neuhausen S L; Godwin A K; Gershoni-Baruch R; Schubert E; Garber J; Stoppa-Lyonnet D; Olah E; Csokay B; Serova O; Lalloo F; Osorio A; Stratton M; Offit K; Boyd J; Caligo M A; Scott R J; Schofield A; Teugels E; Schwab M; Cannon-Albright L; Bishop T; Easton D; Benitez J; King M C; Ponder B A; Weber B; Devilee P; Borg A; Narod S A; Goldgar D
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
American journal of human genetics 1998;62(6):1381-8.
1998: Ford D; Easton D F; Stratton M; Narod S; Goldgar D; Devilee P; Bishop D T; Weber B; Lenoir G; Chang-Claude J; Sobol H; Teare M D; Struewing J; Arason A; Scherneck S; Peto J; Rebbeck T R; Tonin P; Neuhausen S; Barkardottir R; Eyfjord J; Lynch H; Ponder B A; Gayther S A; Zelada-Hedman M
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
American journal of human genetics 1998;62(3):676-89.
1998: Verhoog L C; Brekelmans C T; Seynaeve C; van den Bosch L M; Dahmen G; van Geel A N; Tilanus-Linthorst M M; Bartels C C; Wagner A; van den Ouweland A; Devilee P; Meijers-Heijboer E J; Klijn J G
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.
Lancet 1998;351(9099):316-21.
1997: Petrij-Bosch A; Peelen T; van Vliet M; van Eijk R; Olmer R; Drüsedau M; Hogervorst F B; Hageman S; Arts P J; Ligtenberg M J; Meijers-Heijboer H; Klijn J G; Vasen H F; Cornelisse C J; van 't Veer L J; Bakker E; van Ommen G J; Devilee P
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
Nature genetics 1997;17(3):341-5.
1997: Cornelisse C J; Devilee P
Facts in cancer genetics.
Patient education and counseling 1997;32(1-2):9-17.
1997: Baysal B E; van Schothorst E M; Farr J E; James M R; Devilee P; Richard C W
A high-resolution STS, EST, and gene-based physical map of the hereditary paraganglioma region on chromosome 11q23.
Genomics 1997;44(2):214-21.
1997: DudokdeWit A C; Tibben A; Frets P G; Meijers-Heijboer E J; Devilee P; Klijn J G; Oosterwijk J C; Niermeijer M F
BRCA1 in the family: a case description of the psychological implications.
American journal of medical genetics 1997;71(1):63-71.
1997: Peelen T; van Vliet M; Petrij-Bosch A; Mieremet R; Szabo C; van den Ouweland A M; Hogervorst F; Brohet R; Ligtenberg M J; Teugels E; van der Luijt R; van der Hout A H; Gille J J; Pals G; Jedema I; Olmer R; van Leeuwen I; Newman B; Plandsoen M; van der Est M; Brink G; Hageman S; Arts P J; Bakker M M; Devilee P
A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.
American journal of human genetics 1997;60(5):1041-9.
1997: Devilee P; Hermans J; Eyfjörd J; Bøorresen A L; Lidereau R; Sobol H; Borg A; Cleton-Jansen A M; Oláh E; Cohen B B; Scherneck S; Hamann U; Peterlin B; Caligo M; Bignon Y J; Maugard C
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.
Genes, chromosomes & cancer 1997;18(3):193-9.
1997: Cornelis R S; van Vliet M; van de Vijver M J; Vasen H F; Voute P A; Top B; Khan P M; Devilee P; Cornelisse C J
Three germline mutations in the TP53 gene.
Human mutation 1997;9(2):157-63.
1996: Cornelisse C J; Cornelis R S; Devilee P
Genes responsible for familial breast cancer.
Pathology, research and practice 1996;192(7):684-93.
1996: Oosterwijk J C; Jansen J C; van Schothorst E M; Oosterhof A W; Devilee P; Bakker E; Zoeteweij M W; van der Mey A G
First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas).
Journal of medical genetics 1996;33(5):379-83.
1996: Phelan C M; Rebbeck T R; Weber B L; Devilee P; Ruttledge M H; Lynch H T; Lenoir G M; Stratton M R; Easton D F; Ponder B A; Cannon-Albright L; Larsson C; Goldgar D E; Narod S A
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Nature genetics 1996;12(3):309-11.
1996: van Schothorst E M; Jansen J C; Bardoel A F; van der Mey A G; James M J; Sobol H; Weissenbach J; van Ommen G J; Cornelisse C J; Devilee P
Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genes.
European journal of human genetics : EJHG 1996;4(5):267-73.
1996: Peelen T; Cornelis R S; van Vliet M; Petrij-Bosch A; Cleton-Jansen A M; Meijers-Heijboer H; Klijn J G; Vasen H F; Cornelisse C J; Devilee P
The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.
European journal of human genetics : EJHG 1996;4(4):225-30.
1995: Friend S; Borresen A L; Brody L; Casey G; Devilee P; Gayther S; Goldgar D; Murphy P; Weber B L; Wiseman R
Breast cancer information on the web.
Nature genetics 1995;11(3):238-9.
1995: Cleton-Jansen A M; Collins N; Lakhani S R; Weissenbach J; Devilee P; Cornelisse C J; Stratton M R
Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
British journal of cancer 1995;72(5):1241-4.
1995: Narod S; Ford D; Devilee P; Barkardottir R B; Eyfjord J; Lenoir G; Serova O; Easton D; Goldgar D
Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.
American journal of human genetics 1995;57(4):957-8.
1995: Klijn J G; Devilee P; van Geel A N; Tilanus-Linthorst M M; Dudok-de Wit C; Meijers-Heijboer E J
[Initial Dutch results with a presymptomatic DNA tests in familial breast/ovarian carcinoma. Rotterdamse Werkgroep voor Erfelijke Tumoren]
Nederlands tijdschrift voor geneeskunde 1995;139(9):439-45.
1995: Oosterwijk J C; Devilee P; Meijers-Heijboer E J; Menko F H; Klijn J G; Cornelisse C J
[Cloning of the first gene for breast/ovarian cancer (BRCA1), mapping of a second gene locus (BRCA2) and consequences for clinical practice]
Nederlands tijdschrift voor geneeskunde 1995;139(9):421-3.
1995: Narod S A; Ford D; Devilee P; Barkardottir R B; Lynch H T; Smith S A; Ponder B A; Weber B L; Garber J E; Birch J M
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.
American journal of human genetics 1995;56(1):254-64.
1995: Cleton-Jansen A M; Moerland H W; Callen D F; Doggett N A; Devilee P; Cornelisse C J
Mapping of the breast basic conserved gene (D16S444E) to human chromosome band 16q24.3.
Cytogenetics and cell genetics 1995;68(1-2):49-51.
1994: Devilee P; Cornelisse C J
Somatic genetic changes in human breast cancer.
Biochimica et biophysica acta 1994;1198(2-3):113-30.
1994: Cornelis R S; Cornelisse C J; Devilee P
Selection of families for predictive testing for breast cancer.
Lancet 1994;344(8930):1151.
1994: Devilee P; van Schothorst E M; Bardoel A F; Bonsing B; Kuipers-Dijkshoorn N; James M R; Fleuren G; van der Mey A G; Cornelisse C J
Allelotype of head and neck paragangliomas: allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL.
Genes, chromosomes & cancer 1994;11(2):71-8.
1994: Cornelis R S; van Vliet M; Vos C B; Cleton-Jansen A M; van de Vijver M J; Peterse J L; Khan P M; Børresen A L; Cornelisse C J; Devilee P
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cancer research 1994;54(15):4200-6.
1994: de Wit A C; Meijers-Heijboer E J; Tibben A; Frets P G; Klijn J G; Devilee P; Niermeijer M F
Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer.
Lancet 1994;344(8916):197.
1994: Stratton M R; Ford D; Neuhasen S; Seal S; Wooster R; Friedman L S; King M C; Egilsson V; Devilee P; McManus R
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.
Nature genetics 1994;7(1):103-7.
1994: Cleton-Jansen A M; Moerland E W; Kuipers-Dijkshoorn N J; Callen D F; Sutherland G R; Hansen B; Devilee P; Cornelisse C J
At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer.
Genes, chromosomes & cancer 1994;9(2):101-7.
1994: Cleton-Jansen A M; Moerland H W; Vossen R H; Callen D F; Breuning M H; Devilee P
Dinucleotide repeat polymorphism at D16S533.
Human molecular genetics 1994;3(1):216.
1994: Devilee P; Schuuring E; van de Vijver M J; Cornelisse C J
Recent developments in the molecular genetic understanding of breast cancer.
Critical reviews in oncogenesis 1994;5(2-3):247-70.
1993: Gruis N A; Abeln E C; Bardoel A F; Devilee P; Frants R R; Cornelisse C J
PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue.
British journal of cancer 1993;68(2):308-13.
1993: Bonsing B A; Devilee P; Cleton-Jansen A M; Kuipers-Dijkshoorn N; Fleuren G J; Cornelisse C J
Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.
Cancer research 1993;53(16):3804-11.
1993: Devilee P; Cornelis R S; Bootsma A; Bardoel A; van Vliet M; van Leeuwen I; Cleton F J; de Klein A; Lindhout D; Vasen H F
Linkage to markers for the chromosome region 17q12-q21 in 13 Dutch breast cancer kindreds.
American journal of human genetics 1993;52(4):730-5.
1993: Cornelis R S; Devilee P; van Vliet M; Kuipers-Dijkshoorn N; Kersenmaeker A; Bardoel A; Khan P M; Cornelisse C J
Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions.
Oncogene 1993;8(3):781-5.
1992: Schuuring E; Verhoeven E; van Tinteren H; Peterse J L; Nunnink B; Thunnissen F B; Devilee P; Cornelisse C J; van de Vijver M J; Mooi W J
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.
Cancer research 1992;52(19):5229-34.
1992: Looijenga L H; Oosterhuis J W; Smit V T; Wessels J W; Mollevanger P; Devilee P
Alpha satellite DNAs on chromosomes 10 and 12 are both members of the dimeric suprachromosomal subfamily, but display little identity at the nucleotide sequence level.
Genomics 1992;13(4):1125-32.
1992: Cornelisse C J; Kuipers-Dijkshoorn N; van Vliet M; Hermans J; Devilee P
Fractional allelic imbalance in human breast cancer increases with tetraploidization and chromosome loss.
International journal of cancer. Journal international du cancer 1992;50(4):544-8.
1991: Devilee P; van Vliet M; Cho K R; Vogelstein B
HindIII polymorphism in the DCC gene.
Nucleic acids research 1991;19(24):6965.
1991: Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson P L; Cornelisse C J
Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
Oncogene 1991;6(9):1705-11.
1991: Smit V T; Wessels J W; Mollevanger P; Dauwerse J G; van Vliet M; Beverstock G C; Breuning M H; Devilee P; Raap A K; Cornelisse C J
Improved interpretation of complex chromosomal rearrangements by combined GTG banding and in situ suppression hybridization using chromosome-specific libraries and cosmid probes.
Genes, chromosomes & cancer 1991;3(4):239-48.
1991: Devilee P; van den Broek M; Mannens M; Slater R; Cornelisse C J; Westerveld A; Khan P M
Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood.
International journal of cancer. Journal international du cancer 1991;47(6):817-21.
1991: Devilee P; van Vliet M; Kuipers-Dijkshoorn N; Pearson P L; Cornelisse C J
Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved?
Oncogene 1991;6(2):311-5.
1991: Devilee P; van Vliet M; Bardoel A; Kievits T; Kuipers-Dijkshoorn N; Pearson P L; Cornelisse C J
Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma.
Cancer research 1991;51(3):1020-5.
1990: Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater R M; Westerveld A
Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
Cancer research 1990;50(11):3279-83.
1990: Kievits T; Dauwerse J G; Wiegant J; Devilee P; Breuning M H; Cornelisse C J; van Ommen G J; Pearson P L
Rapid subchromosomal localization of cosmids by nonradioactive in situ hybridization.
Cytogenetics and cell genetics 1990;53(2-3):134-6.
1990: Kievits T; Devilee P; Wiegant J; Wapenaar M C; Cornelisse C J; van Ommen G J; Pearson P L
Direct nonradioactive in situ hybridization of somatic cell hybrid DNA to human lymphocyte chromosomes.
Cytometry 1990;11(1):105-9.
1990: Looijenga L H; Smit V T; Wessels J W; Mollevanger P; Oosterhuis J W; Cornelisse C J; Devilee P
Localization and polymorphism of a chromosome 12-specific alpha satellite DNA sequence.
Cytogenetics and cell genetics 1990;53(4):216-8.
1990: Devilee P; Cornelisse C J; Kuipers-Dijkshoorn N; Jonker C; Pearson P L
Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion.
Cytogenetics and cell genetics 1990;53(1):52-4.
1989: Devilee P; van den Broek M; Kuipers-Dijkshoorn N; Kolluri R; Khan P M; Pearson P L; Cornelisse C J
At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma.
Genomics 1989;5(3):554-60.
1988: Devilee P; Thierry R F; Kievits T; Kolluri R; Hopman A H; Willard H F; Pearson P L; Cornelisse C J
Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes.
Cancer research 1988;48(20):5825-30.
1988: Devilee P; Kievits T; Waye J S; Pearson P L; Willard H F
Chromosome-specific alpha satellite DNA: isolation and mapping of a polymorphic alphoid repeat from human chromosome 10.
Genomics 1988;3(1):1-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Peter Devilee

Research Profile (preview)

Disorders

Genes & Molecular Sequences

Physiology

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Geographic Areas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Peter Devilee (preview)

All Publications